Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
No news for this category today.
----------------------------------------------
** CANCER / ONCOLOGY News **
Human Glioblastoma Tumor Cell Size Reduced By 50 To 70 Percent In Rat Model
http://www.medicalnewstoday.com/articles/119057.php
In a landmark study, Medical College of Wisconsin researchers in Milwaukee report that drugs used to inhibit a specific fatty acid in rat brains with glioblastoma-like tumors not only reduced new blood vessel growth and tumor size dramatically, but also prolonged survival.
American Indians In Northern Plains Have Higher Rates Of Cancer Than Those In Other Regions, Whites, Research Finds
http://www.medicalnewstoday.com/articles/119039.php
American Indians in the Northern Plains region have higher rates of cancer than American Indians in other regions, according to research published in the journal <cite>Cancer</cite>, the <a href="http://www.
Bath Researchers Study How Cancer Cells Come Unstuck
http://www.medicalnewstoday.com/articles/119013.php
Scientists in the Department of Biology & Biochemistry at the University of Bath have started a three year study into the junctions that hold cells together, giving insight into how cancer cells can break off and spread to other parts of the body.
Cancer Therapy: A Role For MAPK Inhibitors Combined With MTORC1 Inhibitors
http://www.medicalnewstoday.com/articles/119009.php
Nearly a decade ago, while it was being tested as an immunosuppressive agent to prevent organ rejection in transplant patients, the drug rapamycin was also discovered to have anti-tumor properties.
Telik's Proteasome Inhibitor Program Meets A Preclinical Development Milestone
http://www.medicalnewstoday.com/articles/119002.php
Telik, Inc. (Nasdaq: TELK) announced that its novel small molecule proteasome inhibitor program met a preclinical development milestone by demonstrating anticancer activity in preclinical models of human leukemia.
Duke Chemists Synthesize Promising Anti-cancer Product
http://www.medicalnewstoday.com/articles/118947.php
Duke University chemists have patented an efficient technique for synthesizing a marine algae extract in sufficient quantities to now test its ability to inhibit the growth of cancerous cells while leaving normal cells unaffected.
Skin 'Odor Profiles' May Open Doors To Early And Noninvasive Skin Cancer Detection And Diagnosis
http://www.medicalnewstoday.com/articles/118943.php
According to new research from the Monell Center, odors from skin can be used to identify basal cell carcinoma, the most common form of skin cancer. The findings, presented at the 236th meeting of the American Chemical Society, may open doors to development of new methods to detect basal cell carcinoma and other forms of skin cancer.
Compact Discs Provide Pain Relief For Scots
http://www.medicalnewstoday.com/articles/118929.php
The <a href="http://www.icr.ac.uk/" target="_blank" rel="nofollow">Institute of Cancer Research </a> is urging Scottish medical professionals to utilise a new free information CD to help manage their patients' pain.
Systems Medicine LLC (SML) Uses OmniComm Systems, Inc. For Electronic Data Capture (EDC) In A Phase II Oncology Study
http://www.medicalnewstoday.com/articles/118927.php
OmniComm Systems, Inc. (OTCBB: OMCM), a leader in integrated EDC solutions for clinical trials, today announced that the company is providing EDC software and services for a Phase II trial in BRCA 1/2 and HNPCC patients sponsored by the Tucson Arizona based biotech, Systems Medicine LLC (SML).
Cancer Survival Up Thanks To Evidence-based Approaches, Says Cancer Council, Australia
http://www.medicalnewstoday.com/articles/118916.php
New research showing a 30 per cent gain in five-year cancer survival since 1986 shows evidence-based cancer control programs are working, Cancer Council Australia said. Speaking on Daffodil Day (22 Aug), Cancer Council Australia Chief Executive Officer, Professor Ian Olver, said the findings of a new government report* on cancer survival and prevalence send three clear messages: - cancer detection and treatment are improving, thanks to evidence-based approaches; - more Australians are living with cancer for longer periods and will require support; and- lack of progress in treating some cancers underscores the ongoing need for research.
Regulus Therapeutics And Collaborators Publish New Data On A Critical Role For MiR-21 In Brain Tumors
http://www.medicalnewstoday.com/articles/118910.php
Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover, develop, and commercialize microRNA-based therapeutics, announced the publication of new research in the journal <i>Molecular and Cellular Biology</i> on the role of the microRNA known as miR-21 in regulating certain cancer cells (1).
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Study Examines Cost-Effectiveness Of HPV Vaccine
http://www.medicalnewstoday.com/articles/119028.php
The cost of administering human papillomavirus vaccines is justified in pre-adolescent girls but becomes less so as the age of women receiving the injection increases, according to a study published Thursday in the <cite>New England Journal of Medicine</cite>, the <a href="http://online.
HPV Vaccine Gardasil Might Not Be Cost-Effective For Adult Women, NEJM Study Says
http://www.medicalnewstoday.com/articles/119018.php
<BR />Vaccinating young teens to prevent cervical cancer might be cost-effective, but a new study questions the cost-effectiveness of vaccinating older teenagers and women in their 20s, the <CITE>Wall Street Journal </CITE>reports.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
NovaRx Initiates Pivotal Phase III Clinical Trial In Lung Cancer Patients
http://www.medicalnewstoday.com/articles/118995.php
NovaRx Corporation announced that the company initiated its pivotal Phase III clinical trial of Lucanix(R) (belagenpumatucel-L) in the treatment of advanced non-small cell lung cancer (NSCLC).
New Drug Delivery System Breaks The 'Mucus Barrier'
http://www.medicalnewstoday.com/articles/118955.php
Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
FDA Approves Vidaza Label Expansion
http://www.medicalnewstoday.com/articles/119043.php
The Aplastic Anemia & MDS International Foundation (AA&MDSIF) is pleased to inform patients that the U.S. Food & Drug Administration (FDA) has expanded the label for VIDAZA (azacitidine) to include data from the AZA-001 trial, which found that Vidaza is the only agent that extends survival in MDS (myelodysplastic syndromes) patients.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Why Hormone Therapy For Prostate Cancer Ultimately Fails
http://www.medicalnewstoday.com/articles/118971.php
Some of the drugs given to many men during their fight against prostate cancer can actually spur some cancer cells to grow, researchers have found. The findings were published online this week in a pair of papers in the <i>Proceedings of the National Academy of Sciences.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment